Press Releases
All Releases
 |
Matrixx Initiatives, Inc. Reports Fiscal 2010 Third Quarter Sales of $28.5 Million and Net Income of $3.8 Million
Jan 25, 2010
|
15.1 KB |
|
| |
SCOTTSDALE, Ariz., Jan 25, 2010 /PRNewswire via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products, today announced financial results for its fiscal third quarter and nine months ended December 31, 2009. Third quarter revenue decreased 26% to $28.5 mi...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results
Jan 22, 2010
|
8.7 KB |
|
| |
SCOTTSDALE, Ariz., Jan 22, 2010 /PRNewswire via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2010 third quarter, ended December 31, 2009, will be released after the market closes on Monday, January 25, 2010. An earnings conference cal...
|
|
Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows
Nov 10, 2009
|
10.7 KB |
|
| |
SCOTTSDALE, Ariz., Nov 10, 2009 /PRNewswire via COMTEX News Network/ -- A recent national survey of 505 pharmacists found that nine out of 10 pharmacists believe it is important for a patient to seek treatment early to help shorten the duration and severity of a cold. And 75 percent of pharmacists say most patients should purchase over-the-counter...
|
|
Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income
Oct 26, 2009
|
15.1 KB |
|
| |
SCOTTSDALE, Ariz., Oct 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products, today announced financial results for its fiscal second quarter and six months ended September 30, 2009. Second quarter revenue decreased 24% ...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of Second Quarter Fiscal 2010 Financial Results
Oct 23, 2009
|
9.1 KB |
|
| |
SCOTTSDALE, Ariz., Oct 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2010 second quarter, ended September 30, 2009, will be released after the market closes on Monday, October 26, 2009. An earnings con...
|
|
Matrixx Initiatives, Inc. Names William J. Hemelt President, CEO and Board Member
Sep 1, 2009
|
8.2 KB |
|
| |
SCOTTSDALE, Ariz., Sept 01, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products, today announced that Matrixx's Board of Directors has named William J. Hemelt as President and Chief Executive Officer, effective August 28, ...
|
|
Matrixx Initiatives to Webcast 2009 Annual Stockholder Meeting Wednesday, August 26, 2009
Aug 24, 2009
|
8.5 KB |
|
| |
SCOTTSDALE, Ariz., Aug 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company will host its 2009 Annual Meeting of Stockholders at 10:00 a.m. PDT on Wednesday, August 26, 2009 at the Westin Kierland in Scottsdale, Arizona. The purpose of the meeting is to elect thr...
|
|
Matrixx Initiatives, Inc. Reports Fiscal 2010 First Quarter Results; Includes Product Recall Costs and Impairment Charges
Aug 10, 2009
|
15.9 KB |
|
| |
SCOTTSDALE, Ariz., Aug 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products, today announced financial results for its fiscal first quarter ended June 30, 2009.
For the first quarter ended June 30, 2009, the Company re...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results
Aug 6, 2009
|
8.9 KB |
|
| |
SCOTTSDALE, Ariz., Aug 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2010 first quarter, ended June 30, 2009, will be released after the market closes on Monday, August 10, 2009. An earnings conference...
|
|
Matrixx Initiatives Confirms Voluntary Recall of Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Gel Swabs
Jun 24, 2009
|
12.5 KB |
|
| |
SCOTTSDALE, Ariz., June 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTTX) has announced that it is in the process of formally notifying retailers, wholesalers and distributors nationwide of its recall of all Zicam Cold Remedy Nasal Gel and Zicam Cold Remedy Gel Swabs. Matrixx Initiatives vigorously...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of Recent FDA Action
Jun 17, 2009
|
9.4 KB |
|
| |
SCOTTSDALE, Ariz., June 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company announced today that they will hold a conference call to discuss recent actions on Thursday, June 18, 2009 at 11:00 AM ET.
To access the teleconference, please call (877) 719-9795 (dome...
|
|
Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel
Jun 16, 2009
|
9.6 KB |
|
| |
SCOTTSDALE, Ariz., June 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX) has confirmed that it received a warning letter today from the U.S. Food and Drug Administration about two of its 19 existing Zicam products, specifically Zicam Cold Remedy Nasal Gel and Zicam Cold Remedy Swabs. The warning le...
|
|
Matrixx Initiatives, Inc. Received a Warning Letter From the Food and Drug Administration
Jun 16, 2009
|
10.0 KB |
|
| |
SCOTTSDALE, Ariz., June 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), today received a Warning Letter from the Food and Drug Administration (the "FDA"). The FDA has asserted that the Company is in violation of its regulations by failing to file a new drug application for its Zicam Cold Remedy ...
|
|
Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46
May 11, 2009
|
16.1 KB |
|
| |
SCOTTSDALE, Ariz., May 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products that provide consumers with "better ways to get better(R)," today announced financial results for its fourth quarter and fiscal year ended Marc...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2009 Financial Results
May 5, 2009
|
9.8 KB |
|
| |
SCOTTSDALE, Ariz., May 5, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," announced today that its financial results for the fiscal fourth quarter and year ended March...
|
|
Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
Feb 13, 2009
|
8.6 KB |
|
| |
SCOTTSDALE, Ariz., Feb 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," will be presenting on Tuesday February 17, 2009, at the Roth Capital Partners 21st Annual OC...
|
|
Matrixx Initiatives, Inc. Reports Third-Quarter Net Sales Increased 26% to $38.7 Million, Net Income Increased to $4.8 Million, or $0.50 Earnings Per Share
Jan 26, 2009
|
16.5 KB |
|
| |
SCOTTSDALE , Ariz., Jan 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- -- Nine Month Net Sales Increased 19% to $80.8 Million and EPS Increased to $1.12
-- Board of Directors Authorizes New Stock Repurchase Program for up to One Million Shares
Matrixx Initiatives, Inc. (Nasdaq: MTXX), a healthcare company that develops and markets ove...
|
|
Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2009 Financial Results
Jan 22, 2009
|
9.9 KB |
|
| |
SCOTTSDALE, Ariz., Jan 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," announced today that financial results for the fiscal 2009 third quarter, ended December 31,...
|
|
Zicam(R) Launches "Cold & Flu Companion" Mobile Application
Dec 2, 2008
|
11.6 KB |
|
| |
SCOTTSDALE, Ariz., Dec 02, 2008 (BUSINESS WIRE) -- Matrixx Initiatives, Inc., makers of Zicam(R) Cold Remedy, today announced
the launch of the Zicam(R) Cold & Flu Companion mobile application for the
T-Mobile G1(TM), the world's first Android-powered phone. The same mobile
application will be released for the iPhone in mid-...
|
|
Matrixx Initiatives, Inc. Reports Second-Quarter Net Income Increased 29% to a Record $8.2 Million, or $0.86 Earnings Per Share, and Net Sales Increased 18% to $33.6 Million
Oct 22, 2008
|
17.0 KB |
|
| |
SCOTTSDALE, Ariz., Oct 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Year-to-Date Net Sales Increased 13% to $42.1 Million
Matrixx Initiatives, Inc. (Nasdaq: MTXX), a healthcare company that develops and markets over-the-counter products that provide consumers with "Better Ways to Get Better(R)," today announced financial results f...
|
|
|
= add release to Briefcase
|
|
